Diverse Role of TGF-β in Kidney Disease

Akagi, 1996, Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis., Kidney Int., 50, 148, 10.1038/ki.1996.297

Ando, 1995, Localization of transforming growth factor-beta and latent transforming growth factor-beta binding protein in rat kidney., Kidney Int., 47, 733, 10.1038/ki.1995.112

Annes, 2003, Making sense of latent TGFbeta activation., J. Cell Sci., 116, 217, 10.1242/jcs.00229

Bitzer, 2000, A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA., Genes Dev., 14, 187, 10.1101/gad.14.2.187

Border, 1990, Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1., Nature, 346, 371, 10.1038/346371a0

Bottinger, 1996, The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice., Proc. Natl. Acad. Sci. U.S.A., 93, 5877, 10.1073/pnas.93.12.5877

Chau, 2012, MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways., Sci. Transl. Med., 4, 10.1126/scitranslmed.3003205

Chen, 2011, The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential., Diabetes, 60, 590, 10.2337/db10-0403

Chen, 2014, MicroRNA-29b inhibits diabetic nephropathy in db/db mice., Mol. Ther., 22, 842, 10.1038/mt.2013.235

Chen, 2018, Central role of dysregulation of TGF-beta/Smad in CKD progression and potential targets of its treatment., Biomed. Pharmacother., 101, 670, 10.1016/j.biopha.2018.02.090

Chen, 2003, Reversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in db/db mice., Biochem. Biophys. Res. Commun., 300, 16, 10.1016/s0006-291x(02)02708-0

Cho, 2007, Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis., Clin. J. Am. Soc. Nephrol., 2, 906, 10.2215/cjn.01050207

Chong, 2006, An expanded WW domain recognition motif revealed by the interaction between Smad7 and the E3 ubiquitin ligase Smurf2., J. Biol. Chem., 281, 17069, 10.1074/jbc.m601493200

Chung, , Smad7 suppresses renal fibrosis via altering expression of TGF-beta/Smad3-regulated microRNAs., Mol. Ther., 21, 388, 10.1038/mt.2012.251

Chung, , miR-192 mediates TGF-beta/Smad3-driven renal fibrosis., J. Am. Soc. Nephrol., 21, 1317, 10.1681/ASN.2010020134

Chung, 2015, MicroRNAs in renal fibrosis., Front. Physiol., 6, 10.3389/fphys.2015.00050

Chung, , MicroRNA and nephropathy: emerging concepts., Int. J. Nephrol. Renovasc. Dis., 6, 169, 10.2147/IJNRD.S37885

Chung, , Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling., J. Am. Soc. Nephrol., 21, 249, 10.1681/ASN.2009010018

Dai, 2015, Smad7 protects against chronic aristolochic acid nephropathy in mice., Oncotarget, 6, 11930, 10.18632/oncotarget.3718

Derynck, 2003, Smad-dependent and Smad-independent pathways in TGF-beta family signalling., Nature, 425, 577, 10.1038/nature02006

Du, 2018, Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-beta1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy., Drug Des. Devel. Ther., 12, 3517, 10.2147/DDDT.S171286

Duan, 2014, Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro., Am. J. Pathol., 184, 2275, 10.1016/j.ajpath.2014.04.014

Dykes, 2017, Transcriptional and post-transcriptional gene regulation by long non-coding RNA., Genomics Proteomics Bioinformatics, 15, 177, 10.1016/j.gpb.2016.12.005

Ebisawa, 2001, Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation., J. Biol. Chem., 276, 12477, 10.1074/jbc.c100008200

Eddy, 2006, Chronic kidney disease progression., J. Am. Soc. Nephrol., 17, 2964, 10.1681/ASN.2006070704

Edeling, 2016, Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog., Nat. Rev. Nephrol., 12, 426, 10.1038/nrneph.2016.54

Ernandez, 2016, The changing landscape of renal inflammation., Trends Mol. Med., 22, 151, 10.1016/j.molmed.2015.12.002

Fan, 1999, Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro., Kidney Int., 56, 1455, 10.1046/j.1523-1755.1999.00656.x

Feng, 2018, TGF-beta mediates renal fibrosis via the Smad3-Erbb4-IR long noncoding RNA axis., Mol. Ther., 26, 148, 10.1016/j.ymthe.2017.09.024

Glassock, 2017, The global burden of chronic kidney disease: estimates, variability and pitfalls., Nat. Rev. Nephrol., 13, 104, 10.1038/nrneph.2016.163

Glowacki, 2013, Increased circulating miR-21 levels are associated with kidney fibrosis., PLoS One, 8, 10.1371/journal.pone.0058014

Gomez-Puerto, 2019, Bone morphogenetic protein receptor signal transduction in human disease., J. Pathol., 247, 9, 10.1002/path.5170

Hall, 2003, The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1., J. Biol. Chem., 278, 10304, 10.1074/jbc.m212334200

Harskamp, 2016, The epidermal growth factor receptor pathway in chronic kidney diseases., Nat. Rev. Nephrol., 12, 496, 10.1038/nrneph.2016.91

Hayashi, 1997, The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling., Cell, 89, 1165, 10.1016/s0092-8674(00)80303-7

He, 2013, MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases., Biochimie, 95, 1355, 10.1016/j.biochi.2013.03.010

Higgins, 2018, TGF-beta1/p53 signaling in renal fibrogenesis., Cell. Signal., 43, 1, 10.1016/j.cellsig.2017.11.005

Hou, 2005, Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney., Am. J. Pathol., 166, 761, 10.1016/s0002-9440(10)62297-3

Huang, , Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease., Am. J. Physiol. Renal Physiol., 295, F118, 10.1152/ajprenal.00021.2008

Huang, , Latent TGF-beta1 protects against crescentic glomerulonephritis., J. Am. Soc. Nephrol., 19, 233, 10.1681/ASN.2007040484

Isaka, 2018, Targeting TGF-beta signaling in kidney fibrosis., Int. J. Mol. Sci., 19, 10.3390/ijms19092532

Jelencsics, 2015, microRNA and kidney transplantation., Adv. Exp. Med. Biol., 888, 271, 10.1007/978-3-319-22671-2_14

Ju, 2006, Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation., Mol. Cell. Biol., 26, 654, 10.1128/mcb.26.2.654-667.2006

Ka, 2007, Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice., J. Am. Soc. Nephrol., 18, 1777, 10.1681/asn.2006080901

Ka, 2012, Kidney-targeting Smad7 gene transfer inhibits renal TGF-beta/MAD homologue (SMAD) and nuclear factor kappaB (NF-kappaB) signalling pathways, and improves diabetic nephropathy in mice., Diabetologia, 55, 509, 10.1007/s00125-011-2364-5

Kopp, 1996, Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease., Lab Invest., 74, 991

Kriegel, 2012, The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury., Physiol. Genomics, 44, 237, 10.1152/physiolgenomics.00141.2011

Kulkarni, 1993, Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death., Proc. Natl. Acad. Sci. U.S.A., 90, 770, 10.1073/pnas.90.2.770

Kusakabe, 2008, The structure of the TGF-beta latency associated peptide region determines the ability of the proprotein convertase furin to cleave TGF-betas., J. Cell. Biochem., 103, 311, 10.1002/jcb.21407

Lai, 2015, MicroRNA-21 in glomerular injury., J. Am. Soc. Nephrol., 26, 805, 10.1681/ASN.2013121274

Lan, 2008, Smad7 as a therapeutic agent for chronic kidney diseases., Front. Biosci., 13, 4984, 10.2741/3057

Lan, 2011, Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation., Int. J. Biol. Sci., 7, 1056, 10.7150/ijbs.7.1056

Lan, 2012, TGF-beta/Smad signaling in kidney disease., Semin. Nephrol., 32, 236, 10.1016/j.semnephrol.2012.04.002

Lan, 2003, Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model., J. Am. Soc. Nephrol., 14, 1535, 10.1097/01.asn.0000067632.04658.b8

Lancaster, 2017, Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis., Eur. Respir. Rev., 26, 10.1183/16000617.0057-2017

Li, 2017, Inflammation drives renal scarring in experimental pyelonephritis., Am. J. Physiol. Renal Physiol., 312, F43, 10.1152/ajprenal.00471.2016

Li, 2010, Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy., Diabetes, 59, 2612, 10.2337/db09-1631

Li, 2002, Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation., J. Am. Soc. Nephrol., 13, 1464, 10.1097/01.asn.0000014252.37680.e4

Li, 2008, TGF-beta: a master of all T cell trades., Cell, 134, 392, 10.1016/j.cell.2008.07.025

Li, 2013, The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-beta/Smad3-Azin1 pathway., Kidney Int., 84, 1129, 10.1038/ki.2013.272

Liu, 2008, Arkadia regulates TGF-beta signaling during renal tubular epithelial to mesenchymal cell transition., Kidney Int., 73, 588, 10.1038/sj.ki.5002713

Liu, 2013, Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-beta/Smad3-NF.kappaB-dependent mechanisms in mice., PLoS One, 8, 10.1371/journal.pone.0053573

Liu, 2014, Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension., Clin. Sci., 127, 195, 10.1042/CS20130706

Liu, 2018, Preparation and evaluation of anti-renal fibrosis activity of novel truncated TGF-beta receptor type II., Biotechnol. Appl. Biochem., 65, 834, 10.1002/bab.1667

Liu, 2011, Cellular and molecular mechanisms of renal fibrosis., Nat. Rev. Nephrol., 7, 684, 10.1038/nrneph.2011.149

Liu, 2012, Smad3 mediates ANG II-induced hypertensive kidney disease in mice., Am. J. Physiol. Renal Physiol., 302, F986, 10.1152/ajprenal.00595.2011

Loeffler, 2018, FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy., Cell Tissue Res., 372, 115, 10.1007/s00441-017-2754-1

Lopez-Hernandez, 2012, Role of TGF-beta in chronic kidney disease: an integration of tubular, glomerular and vascular effects., Cell Tissue Res., 347, 141, 10.1007/s00441-011-1275-6

Luo, 2017, Signaling cross talk between TGF-beta/Smad and other signaling pathways., Cold Spring Harb. Perspect. Biol., 9, 10.1101/cshperspect.a022137

Lv, 2013, MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis., Am. J. Physiol. Renal Physiol., 305, F1220, 10.1152/ajprenal.00148.2013

Massagué, 2012, TGFβ signalling in context., Nat. Rev. Mol. Cell Biol., 13, 616, 10.1038/nrm3434

McClelland, 2015, miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7., Clin. Sci., 129, 1237, 10.1042/CS20150427

Meng, 2019, Inflammatory mediators and renal fibrosis., Adv. Exp. Med. Biol., 1165, 381, 10.1007/978-981-13-8871-2_18

Meng, 2013, Role of the TGF-beta/BMP-7/Smad pathways in renal diseases., Clin. Sci., 124, 243, 10.1042/CS20120252

Meng, 2010, Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis., J. Am. Soc. Nephrol., 21, 1477, 10.1681/ASN.2009121244

Meng, , Diverse roles of TGF-beta receptor II in renal fibrosis and inflammation in vivo and in vitro., J. Pathol., 227, 175, 10.1002/path.3976

Meng, , Disruption of Smad4 impairs TGF-beta/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro., Kidney Int., 81, 266, 10.1038/ki.2011.327

Meng, 2014, Inflammatory processes in renal fibrosis., Nat. Rev. Nephrol., 10, 493, 10.1038/nrneph.2014.114

Meng, 2016, TGF-beta: the master regulator of fibrosis., Nat Rev Nephrol, 12, 325, 10.1038/nrneph.2016.48

Meng, 2015, Treatment of renal fibrosis by rebalancing TGF-beta/Smad signaling with the combination of asiatic acid and naringenin., Oncotarget, 6, 36984, 10.18632/oncotarget.6100

Mihai, 2018, Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome., J. Immunol. Res., 2018, 10.1155/2018/2180373

Miyajima, 2000, Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction., Kidney Int., 58, 2301, 10.1046/j.1523-1755.2000.00414.x

Miyazawa, 2017, Regulation of TGF-beta family signaling by inhibitory smads., Cold Spring Harb. Perspect. Biol., 9, 10.1101/cshperspect.a022095

Moghaddas Sani, 2018, Long non-coding RNAs: an essential emerging field in kidney pathogenesis., Biomed. Pharmacother., 99, 755, 10.1016/j.biopha.2018.01.122

Morishita, 2014, siRNAs targeted to Smad4 prevent renal fibrosis in vivo., Sci. Rep., 4, 10.1038/srep06424

Munoz-Felix, 2015, TGF-beta/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?, Pharmacol. Ther., 156, 44, 10.1016/j.pharmthera.2015.10.003

Nagarajan, 2000, Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB., Biochem. J., 591, 10.1042/bj3480591

Nakao, 1997, Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling., Nature, 389, 631, 10.1038/39369

Ng, 1999, Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation., Nephrol. Dial. Transplant., 14, 2860, 10.1093/ndt/14.12.2860

Ng, 2005, Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney., Kidney Int., 94, S83, 10.1111/j.1523-1755.2005.09421.x

Nie, 2014, Effects of astragalus injection on the TGFbeta/Smad pathway in the kidney in type 2 diabetic mice., BMC Complement. Altern. Med., 14, 10.1186/1472-6882-14-148

Nikolic-Paterson, 2014, Macrophages promote renal fibrosis through direct and indirect mechanisms., Kidney Int., 4, 34, 10.1038/kisup.2014.7

Oba, 2010, miR-200b precursor can ameliorate renal tubulointerstitial fibrosis., PLoS One, 5, 10.1371/journal.pone.0013614

Provenzano, 2019, Unraveling cardiovascular risk in renal patients: a new take on old tale., Front. Cell Dev. Biol., 7, 10.3389/fcell.2019.00314

Qi, 2017, High expression of long non-coding RNA ATB is associated with poor prognosis in patients with renal cell carcinoma., Eur. Rev. Med. Pharmacol. Sci., 21, 2835

Qin, 2011, TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29., J. Am. Soc. Nephrol., 22, 1462, 10.1681/ASN.2010121308

Qiu, 2017, Transforming growth factor-beta activated long non-coding RNA ATB plays an important role in acute rejection of renal allografts and may impacts the postoperative pharmaceutical immunosuppression therapy., Nephrology, 22, 796, 10.1111/nep.12851

Qu, 2015, The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction., Kidney Int., 88, 1323, 10.1038/ki.2015.235

Rane, 2019, Krupsilonppel-like factors (KLFs) in renal physiology and disease., EBioMedicine, 40, 743, 10.1016/j.ebiom.2019.01.021

Roberts, 1991, Multiple forms of TGF-beta: distinct promoters and differential expression., Ciba Found Symp., 157, 7

Romagnani, 2017, Chronic kidney disease., Nat. Rev. Dis. Primers, 3, 10.1038/nrdp.2017.88

Saharinen, 1999, Latent transforming growth factor-beta binding proteins (LTBPs)–structural extracellular matrix proteins for targeting TGF-beta action., Cytokine Growth Factor Rev., 10, 99, 10.1016/s1359-6101(99)00010-6

Samarakoon, 2013, Induction of renal fibrotic genes by TGF-beta1 requires EGFR activation, p53 and reactive oxygen species., Cell. Signal., 25, 2198, 10.1016/j.cellsig.2013.07.007

Sanz, 2010, NF-kappaB in renal inflammation., J. Am. Soc. Nephrol., 21, 1254, 10.1681/ASN.2010020218

Sharma, 2011, Pirfenidone for diabetic nephropathy., J. Am. Soc. Nephrol., 22, 1144, 10.1681/ASN.2010101049

Sun, 2017, Transcriptome identified lncRNAs associated with renal fibrosis in UUO rat model., Front. Physiol., 8, 10.3389/fphys.2017.00658

Sun, 2018, Novel lncRNA Erbb4-IR promotes diabetic kidney injury in db/db mice by targeting miR-29b., Diabetes, 67, 731, 10.2337/db17-0816

Sureshbabu, 2016, TGF-beta signaling in the kidney: profibrotic and protective effects., Am. J. Physiol. Renal Physiol., 310, F596, 10.1152/ajprenal.00365.2015

Sutaria, 1998, Transforming growth factor-beta receptor types I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction., Life Sci., 62, 1965, 10.1016/s0024-3205(98)00166-0

Tang, 2018, Transforming growth factor-beta signalling in renal fibrosis: from Smads to non-coding RNAs., J. Physiol., 596, 3493, 10.1113/JP274492

Tang, 2019, Macrophages: versatile players in renal inflammation and fibrosis., Nat. Rev. Nephrol., 15, 144, 10.1038/s41581-019-0110-2

Tian, 2015, Ubiquitination and regulation of Smad7 in the TGF-beta1/Smad signaling of aristolochic acid nephropathy., Toxicol. Mech. Methods, 25, 645, 10.3109/15376516.2015.1061082

Trachtman, 2011, A phase 1, single-dose study of fresolimumab, an anti-TGF-beta antibody, in treatment-resistant primary focal segmental glomerulosclerosis., Kidney Int., 79, 1236, 10.1038/ki.2011.33

Troncone, 2018, Transforming growth factor-beta1/Smad7 in intestinal immunity, inflammation, and cancer., Front. Immunol., 9, 10.3389/fimmu.2018.01407

Tsuchida, 2003, Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells., Kidney Int., 63, 2000, 10.1046/j.1523-1755.2003.00009.x

Vincenti, 2017, A Phase 2, double-blind, placebo-controlled, randomized study of fresolimumab in patients with steroid-resistant primary focal segmental glomerulosclerosis., Kidney Int. Rep., 2, 800, 10.1016/j.ekir.2017.03.011

Voelker, 2017, Anti-TGF-beta1 antibody therapy in patients with diabetic nephropathy., J. Am. Soc. Nephrol., 28, 953, 10.1681/ASN.2015111230

Wan, 2014, Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-beta1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo., J. Ethnopharmacol., 151, 1079, 10.1016/j.jep.2013.12.005

Wang, 2014, Transforming growth factor-beta1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b., Kidney Int., 85, 352, 10.1038/ki.2013.372

Wang, 2012, Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis., J. Am. Soc. Nephrol., 23, 252, 10.1681/ASN.2011010055

Wang, 2019, Exosome-mediated miR-29 transfer reduces muscle atrophy and kidney fibrosis in mice., Mol. Ther., 27, 571, 10.1016/j.ymthe.2019.01.008

Wang, 2018, Long noncoding RNA lnc-TSI inhibits renal fibrogenesis by negatively regulating the TGF-beta/Smad3 pathway., Sci. Transl. Med., 10, 10.1126/scitranslmed.aat2039

Wang, 2006, Essential role of Smad3 in angiotensin II-induced vascular fibrosis., Circ. Res., 98, 1032, 10.1161/01.res.0000218782.52610.dc

Wang, , Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7., J. Am. Soc. Nephrol., 16, 1371, 10.1681/asn.2004121070

Wang, , Transforming growth factor-beta and Smad signalling in kidney diseases., Nephrology, 10, 48, 10.1111/j.1440-1797.2005.00334.x

Wang, 2017, Role of endothelial-to-mesenchymal transition induced by TGF-beta1 in transplant kidney interstitial fibrosis., J. Cell. Mol. Med., 21, 2359, 10.1111/jcmm.13157

Weiskirchen, 2009, BMP-7 as antagonist of organ fibrosis., Front. Biosci., 14, 4992, 10.2741/3583

Xianyuan, 2019, Anti-renal fibrosis effect of asperulosidic acid via TGF-beta1/smad2/smad3 and NF-kappaB signaling pathways in a rat model of unilateral ureteral obstruction., Phytomedicine, 53, 274, 10.1016/j.phymed.2018.09.009

Xiao, 2019, LncRNA ENST00000453774.1 contributes to oxidative stress defense dependent on autophagy mediation to reduce extracellular matrix and alleviate renal fibrosis., J. Cell. Physiol., 234, 9130, 10.1002/jcp.27590

Xie, 2016, Long non-coding RNA-H19 antagonism protects against renal fibrosis., Oncotarget, 7, 51473, 10.18632/oncotarget.10444

Yan, 2011, Smad7: not only a regulator, but also a cross-talk mediator of TGF-beta signalling., Biochem. J., 434, 1, 10.1042/BJ20101827

Yan, 2016, Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-beta (TGF-beta)/Smad Signaling., J. Biol. Chem., 291, 382, 10.1074/jbc.M115.694281

Yan, 2009, Regulation of TGF-beta signaling by Smad7., Acta Biochim. Biophys. Sin., 41, 263, 10.1093/abbs/gmp018

Yang, 2009, Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3., Hypertension, 54, 877, 10.1161/HYPERTENSIONAHA.109.136531

Yaswen, 1996, Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse., Blood, 87, 1439, 10.1182/blood.v87.4.1439.bloodjournal8741439

Yu, 2014, MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis., Lab Invest., 94, 978, 10.1038/labinvest.2014.91

Yu, 2019, Gene expression profiling analysis reveals that the long non-coding RNA uc.412 is involved in mesangial cell proliferation., Mol. Med. Rep., 20, 5297, 10.3892/mmr.2019.10753

Zarjou, 2011, Identification of a microRNA signature in renal fibrosis: role of miR-21., Am. J. Physiol. Renal Physiol., 301, F793, 10.1152/ajprenal.00273.2011

Zhang, 2014, miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-beta/Smad3 signaling., Mol. Ther., 22, 974, 10.1038/mt.2014.25

Zhang, 2018, The preventive and therapeutic implication for renal fibrosis by targetting TGF-beta/Smad3 signaling., Clin. Sci., 132, 1403, 10.1042/CS20180243

Zhang, 2013, Meeting report - TGF-beta superfamily: signaling in development and disease., J. Cell Sci., 126, 4809, 10.1242/jcs.142398

Zhang, 2019, LRNA9884, a Novel Smad3-Dependent Long Noncoding RNA, Promotes Diabetic Kidney Injury in db/db Mice via Enhancing MCP-1-Dependent Renal Inflammation., Diabetes, 68, 1485, 10.2337/db18-1075

Zhao, 2016, Therapeutic effects of tangshen formula on diabetic nephropathy in rats., PLoS One, 11, 10.1371/journal.pone.0147693

Zhong, 2013, miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes., Diabetologia, 56, 663, 10.1007/s00125-012-2804-x

Zhong, 2011, Smad3-mediated upregulation of miR-21 promotes renal fibrosis., J. Am. Soc. Nephrol., 22, 1668, 10.1681/ASN.2010111168

Zhou, 2018, Loss of Smad7 promotes inflammation in rheumatoid arthritis., Front. Immunol., 9, 10.3389/fimmu.2018.02537

Zhou, 2019, Livin is involved in TGF-beta1-induced renal tubular epithelial-mesenchymal transition through lncRNA-ATB., Ann. Transl. Med., 7, 10.21037/atm.2019.08.29

Zhou, 2010, Mechanism of chronic aristolochic acid nephropathy: role of Smad3., Am. J. Physiol. Renal Physiol., 298, F1006, 10.1152/ajprenal.00675.2009

Zhou, 2014, Identification of novel long noncoding RNAs associated with TGF-beta/Smad3-mediated renal inflammation and fibrosis by RNA sequencing., Am. J. Pathol., 184, 409, 10.1016/j.ajpath.2013.10.007

Zhou, 2015, Long noncoding RNA Arid2-IR is a novel therapeutic target for renal inflammation., Mol. Ther., 23, 1034, 10.1038/mt.2015.31

Zhou, 2018, Silencing of LncRNA TCONS_00088786 reduces renal fibrosis through miR-132., Eur. Rev. Med. Pharmacol. Sci., 22, 166, 10.26355/eurrev_201801_14114

Zhou, 2013, miR-21-containing microvesicles from injured tubular epithelial cells promote tubular phenotype transition by targeting PTEN protein., Am. J. Pathol., 183, 1183, 10.1016/j.ajpath.2013.06.032

Ziyadeh, 2000, Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice., Proc. Natl. Acad. Sci. U.S.A., 97, 8015, 10.1073/pnas.120055097